Aziyo is a regenerative medicine platform company created by spinning out and capitalizing the musculoskeletal division of Tissue Banks International, a non-profit organization. The company brings together two seasoned management teams from the wound care industry from Advanced BioHealing and Osiris. Aziyo is a commercial stage company with multiple products.
The company is positioned as a platform to handle future growth from a combination of an increasing pipeline of new products, new customers, and potential acquisitions. Deerfield invested in Aziyo Biologics through its $19.5 million Series A Preferred Equity offering. The capital will be used to continue to grow the business.